Linqi Zhang

Title: Innovations by Linqi Zhang in Genomic Research

Introduction

Linqi Zhang is a prominent inventor based in New York, NY (US), known for his significant contributions to genomic research. He holds a patent that focuses on methods for identifying genomic equivalent markers, which are crucial for quantitating cells and polynucleotide sequences.

Latest Patents

Linqi Zhang's patent, titled "Methods for identifying genomic equivalent markers and their use in quantitating cells and polynucleotide sequences therein," describes innovative techniques for determining genetic sequences that serve as genomic equivalent markers for various organisms. The method involves calculating the ratio of wild type and mutant amplicons across multiple samples from organisms that are heterozygous for specific mutations. This approach allows researchers to establish the number of copies of a particular genetic sequence per genome, which can then be utilized to normalize the analysis of other target sequences based on their abundance per cell. For instance, the CCR5 gene was identified to have 2 copies per genome, which was instrumental in measuring the number of copies per cell of HIV-1 provirions and other relevant markers.

Career Highlights

Linqi Zhang is affiliated with The Rockefeller University, where he continues to advance the field of genomics through his research and innovations. His work has implications for understanding genetic variations and their effects on health and disease.

Collaborations

Linqi Zhang has collaborated with notable researchers in the field, including Sharon R. Lewin and Leondios Kostrikis. These collaborations have further enriched his research and contributed to the advancement of genomic studies.

Conclusion

Linqi Zhang's innovative methods for identifying genomic equivalent markers represent a significant advancement in genomic research. His contributions are vital for the ongoing exploration of genetic sequences and their applications in various biological contexts.